HomeSYNACT • STO
add
SynAct Pharma AB
Previous close
kr 21.50
Day range
kr 20.95 - kr 22.15
Year range
kr 7.24 - kr 25.30
Market cap
1.14B SEK
Avg Volume
175.04K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 30.34M | 58.32% |
Net income | -27.52M | -47.75% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 8.43% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 68.89M | 9.70% |
Total assets | 243.60M | 1.05% |
Total liabilities | 47.18M | -12.72% |
Total equity | 196.41M | — |
Shares outstanding | 49.87M | — |
Price to book | 5.46 | — |
Return on assets | -32.79% | — |
Return on capital | -39.85% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -27.52M | -47.75% |
Cash from operations | -18.79M | 48.03% |
Cash from investing | — | — |
Cash from financing | 35.97M | -24.25% |
Net change in cash | 17.73M | 57.65% |
Free cash flow | -10.04M | 69.59% |
About
Founded
Mar 14, 2012
Website
Employees
6
